Skip to main navigation menu Skip to main content Skip to site footer

Research Articles

Early Access

Ethnobotanical value of Withania coagulans against carbapenem-resistant UTI pathogens

DOI
https://doi.org/10.14719/pst.12844
Submitted
21 November 2025
Published
06-02-2026

Abstract

Antibiotic resistance has become a major global health concern due to the emergence of carbapenem-resistant bacterial species that diminish the effectiveness of conventional antibiotics. Because of this, researchers are increasingly turning to herbal products as alternative sources of antibacterial compounds. The present study aimed to evaluate the phytochemical profile and effectiveness of Withania coagulans activity on carbapenem-resistant pathogens. The phytochemicals were extracted by the Soxhlet extraction method with different solvents and major phytochemicals were quantified and analyzed by Gas chromatography-mass spectrometry (GC-MS). The antibacterial effect of the standard and extract was determined by the disc diffusion method as per Clinical Laboratory Standards Institute (CLSI) guidelines against drug resistant pathogens and the compound interaction was studied by the in silico docking method. The polar solvent showed significant yield and content of phytochemicals. The maximum yield was 3.42 %, with 11.67 mg/g of alkaloids, 12.13 mg/g of flavonoids and 6.87 mg/g of phenols, followed by ethyl acetate. Antibiotic resistance among clinical isolates was found to be 67.5 % for the resistant pattern to imipenem, followed by doripenem (62.5 %), ertapenem (60 %) and meropenem (57.5 %). The effect of extract on resistant strains was best in nonpolar extraction and less significant among polar solvents. The hexane extract and chloroform extract had the highest inhibition (26 mm), especially on Proteus vulgaris and Klebsiella pneumoniae. Molecular docking of the GC-MS-produced molecule 2,4-Dihydroxypropiophenone has shown that the molecule is a good binding molecule in the carbapenemase active site, confirming the antibacterial activity of the extract. The findings confirm that the extract of W. coagulans had significant antibacterial activity and could serve as a promising natural phytoremedy to overcome the emerging extended-spectrum beta-lactamase (ESBL) drug resistance infections. Formulation with nanotechnology and in vivo studies will be essential to validate the therapeutic potential for future clinical application.

References

  1. 1. Dilnaz K, Jay SU, Chintankumar JT, Vishal D, Vinit D, Sudhanshu M. A brief review on Withania coagulans. Int J Pharm Res Appl. 2025;10:2070–82. https://doi.org/10.35629/4494-100220702082
  2. 2. Pooja S, Rahul K, Arti S, Praveen Kumar G. Comprehensive review on Withania coagulans Dunal: unveiling pharmacognosy, phytochemistry and pharmacological potentials. Pharmacogn Rev. 2024;18:47–59. https://doi.org/10.5530/phrev.2024.18.5
  3. 3. Khan MI, Maqsood M, Saeed RA, Alam A, Sahar A, Kieliszek M, et al. Phytochemistry, food application and therapeutic potential of the medicinal plant Withania coagulans: a review. Molecules. 2021;26:6881. https://doi.org/10.3390/molecules26226881
  4. 4. Seyed Alinaghi SA, Mehraeen E, Mirzapour P, et al. A systematic review on natural products with antimicrobial potential against WHO priority pathogens. Eur J Med Res. 2025;30:525. https://doi.org/10.1186/s40001-025-02717-x
  5. 5. Khan A, Younis T, Anas M, Ali M, Shinwari ZK, Khalil AT, et al. Withania coagulans-mediated green synthesis of silver nanoparticles: characterization and assessment of their phytochemical, antioxidant, toxicity and antimicrobial activities. BMC Plant Biol. 2025;25:574. https://doi.org/10.1186/s12870-025-06533-7
  6. 6. Maher S, Zamina B, Riaz M, Riaz S, Khalid N, Imran M, et al. Green synthesis of Withania coagulans extract-mediated zinc oxide nanoparticles as photocatalysts and biological agents. ACS Omega. 2023;8:46715–27. https://doi.org/10.1021/acsomega.3c05947
  7. 7. AlSheikh HMA, Sultan I, Kumar V, Rather IA, Al-Sheikh H, Tasleem Jan A, et al. Plant-based phytochemicals as possible alternative to antibiotics in combating bacterial drug resistance. Antibiotics (Basel). 2020;9:480. https://doi.org/10.3390/antibiotics9080480
  8. 8. Seukep AJ, Kuete V, Nahar L, Sarker SD, Guo M. Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification. J Pharm Anal. 2020;10:277–90. https://doi.org/10.1016/j.jpha.2019.11.002
  9. 9. Azwanida NN. A review on the extraction methods used in medicinal plants: principle, strength and limitation. Med Aromat Plants. 2015;4:196.
  10. 10. Urnukhsaikhan E, Bold BE, Gunbileg A, et al. Antibacterial activity and characteristics of silver nanoparticles biosynthesized from Carduus crispus. Sci Rep. 2021;11:21047. https://doi.org/10.1038/s41598-021-00520-2
  11. 11. Da Silva RF, Carneiro CN, De Sousa CBDC, Gomez FJ, Espino M, Boiteux J, et al. Sustainable extraction bioactive compounds procedures in medicinal plants based on the principles of green analytical chemistry: a review. Microchem J. 2022;175:107184. https://doi.org/10.1016/j.microc.2022.107184
  12. 12. Siddiqui T, Sharma V, Khan MU, Gupta K. Terpenoids in essential oils: chemistry, classification and potential impact on human health and industry. Phytomed Plus. 2024;4:100549. https://doi.org/10.1016/j.phyplu.2024.100549
  13. 13. Shanmugam KR, Shanmugam B, Subbaiah GV, Ravi S, Reddy KS. Medicinal plants and bioactive compounds for diabetes management: important advances in drug discovery. Curr Pharm Des. 2021;27:763–74. https://doi.org/10.2174/1381612826666200928160357
  14. 14. Chatepa LEC, Mwamatope B, Chikowe I, Masamba KG. Effects of solvent extraction on the phytoconstituents and in vitro antioxidant activity properties of leaf extracts of two selected medicinal plants from Malawi. BMC Complement Med Ther. 2024;24:317. https://doi.org/10.1186/s12906-024-04619-7
  15. 15. Bibi H, Maher S, Khan N, Khan S, Chohan TA, Saleem H, et al. Isolation and characterization of bioactive constituents from Withania coagulans Dunal with antioxidant and multifunctional enzyme inhibition potential, supported by docking, MD and DFT studies. RSC Adv. 2025;15:48566–84. https://doi.org/10.1039/D5RA04491J
  16. 16. Raj N, Agarwal A, Chaturvedi N. In vitro study on total phenols, flavonoids content and DPPH activity of Withania species. Int J Environ Agric Biotechnol. 2017;2:946–50. https://doi.org/10.22161/ijeab/2.2.49
  17. 17. Abubakar AR, Haque M. Preparation of medicinal plants: basic extraction and fractionation procedures for experimental purposes. J Pharm Bioallied Sci. 2020;12:1–10. https://doi.org/10.4103/jpbs.JPBS_175_19
  18. 18. Tzanova M, Atanasov V, Yaneva Z, Ivanova D, Denev P. Influence of solvent polarity on the extraction of phenolic compounds from plant materials. Processes. 2020;8:614. https://doi.org/10.3390/pr8101222
  19. 19. Sanskruti P, Shubhangi M, Gajanan S. Phytochemical and pharmacological screening of Withania coagulans. World J Biol Pharm Health Sci. 2023;16:109–17. https://doi.org/10.30574/wjbphs.2023.16.3.0501
  20. 20. Nawaz H, Shad MA, Rehman N, andaleeb H, Ullah N. Effect of solvent polarity on extraction yield and antioxidant properties of phytochemicals from bean seeds. Braz J Pharm Sci. 2020;56:e17129. https://doi.org/10.1590/s2175-97902019000417129
  21. 21. Do QD, Angkawijaya AE, Tran-Nguyen PL, et al. Effect of extraction solvent on total phenol content, total flavonoid content and antioxidant activity of Limnophila aromatica. J Food Drug Anal. 2014;22:296–302. https://doi.org/10.1016/j.jfda.2013.11.001
  22. 22. Pawar S, Mohite S, Shinde R, Patil S, Karande G. Carbapenem-resistant Enterobacteriaceae: prevalence and bacteriological profile in a tertiary teaching hospital from rural western India. Indian J Microbiol Res. 2018;5:342–47. https://doi.org/10.18231/2394-5478.2018.0072
  23. 23. Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15. https://doi.org/10.1038/nature.2017.21550
  24. 24. Gandham P, Arumugam K. Antimicrobial resistance patterns of Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections: a prospective study. Int J Res Med Sci. 2025;13:3715–19. https://doi.org/10.18203/2320-6012.ijrms20252781
  25. 25. Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215:S28–36. https://doi.org/10.1093/infdis/jiw282
  26. 26. Prashik K, Pratiksha K, Prachi K, Kajave M, Snehal K. Phytochemical screening and evaluation of antimicrobial activity of Withania coagulans. Int J Pharm Res Appl. 2022;7:998–1005.
  27. 27. Nazir I, Intisar A, Din MI, Khan JS, Ahmed E, Aamir A, et al. Volatile composition and antibacterial activity of fruits of Withania coagulans Dunal. Pak J Sci Ind Res Ser A. 2023;66A:227–33.
  28. 28. Nazneen P, Sayed N, Das N. Antimicrobial and phytochemical screening of methanolic fruit extract of Withania coagulans Dunal for evaluating antidiabetic activity. Pharma Innov J. 2018;7:197–204.
  29. 29. Ali A, Jameel M, Ali M. Analysis of fatty acid composition of Withania coagulans fruits by gas chromatography–mass spectrometry. Res J Pharmacogn. 2017;4:1–6.
  30. 30. Shrestha RLS, Adhikari J, Subin S. Phytochemicals of Withania coagulans against androgen receptor: an in silico insight. J King Saud Univ Sci. 2024;36:103558. https://doi.org/10.1016/j.jksus.2024.103558

Downloads

Download data is not yet available.